These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19724058)

  • 1. MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9.
    Gilles L; Bluteau D; Boukour S; Chang Y; Zhang Y; Robert T; Dessen P; Debili N; Bernard OA; Vainchenker W; Raslova H
    Blood; 2009 Nov; 114(19):4221-32. PubMed ID: 19724058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin dynamics control SRF activity by regulation of its coactivator MAL.
    Miralles F; Posern G; Zaromytidou AI; Treisman R
    Cell; 2003 May; 113(3):329-42. PubMed ID: 12732141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum response factor is an essential transcription factor in megakaryocytic maturation.
    Halene S; Gao Y; Hahn K; Massaro S; Italiano JE; Schulz V; Lin S; Kupfer GM; Krause DS
    Blood; 2010 Sep; 116(11):1942-50. PubMed ID: 20525922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
    Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
    Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for MKL1 in megakaryocytic maturation.
    Cheng EC; Luo Q; Bruscia EM; Renda MJ; Troy JA; Massaro SA; Tuck D; Schulz V; Mane SM; Berliner N; Sun Y; Morris SW; Qiu C; Krause DS
    Blood; 2009 Mar; 113(12):2826-34. PubMed ID: 19136660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency.
    Jalagadugula G; Mao G; Kaur G; Goldfinger LE; Dhanasekaran DN; Rao AK
    Blood; 2010 Dec; 116(26):6037-45. PubMed ID: 20876458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation.
    Selvaraj A; Prywes R
    J Biol Chem; 2003 Oct; 278(43):41977-87. PubMed ID: 14565952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant actins that stabilise F-actin use distinct mechanisms to activate the SRF coactivator MAL.
    Posern G; Miralles F; Guettler S; Treisman R
    EMBO J; 2004 Oct; 23(20):3973-83. PubMed ID: 15385960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear translocation of the SRF co-activator MAL in cortical neurons: role of RhoA signalling.
    Tabuchi A; Estevez M; Henderson JA; Marx R; Shiota J; Nakano H; Baraban JM
    J Neurochem; 2005 Jul; 94(1):169-80. PubMed ID: 15953360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells.
    Luo XG; Zhang CL; Zhao WW; Liu ZP; Liu L; Mu A; Guo S; Wang N; Zhou H; Zhang TC
    Cancer Lett; 2014 Mar; 344(1):129-137. PubMed ID: 24189459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation.
    Smith EC; Teixeira AM; Chen RC; Wang L; Gao Y; Hahn KL; Krause DS
    Blood; 2013 Feb; 121(7):1094-101. PubMed ID: 23243284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation.
    Smith EC; Thon JN; Devine MT; Lin S; Schulz VP; Guo Y; Massaro SA; Halene S; Gallagher P; Italiano JE; Krause DS
    Blood; 2012 Sep; 120(11):2317-29. PubMed ID: 22806889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.
    Johnson LA; Rodansky ES; Haak AJ; Larsen SD; Neubig RR; Higgins PD
    Inflamm Bowel Dis; 2014 Jan; 20(1):154-65. PubMed ID: 24280883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OTT-MAL is a deregulated activator of serum response factor-dependent gene expression.
    Descot A; Rex-Haffner M; Courtois G; Bluteau D; Menssen A; Mercher T; Bernard OA; Treisman R; Posern G
    Mol Cell Biol; 2008 Oct; 28(20):6171-81. PubMed ID: 18710951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAL and ternary complex factor use different mechanisms to contact a common surface on the serum response factor DNA-binding domain.
    Zaromytidou AI; Miralles F; Treisman R
    Mol Cell Biol; 2006 Jun; 26(11):4134-48. PubMed ID: 16705166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation.
    Eckly A; Strassel C; Freund M; Cazenave JP; Lanza F; Gachet C; Léon C
    Blood; 2009 Apr; 113(14):3182-9. PubMed ID: 18984861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for Rab27b in NF-E2-dependent pathways of platelet formation.
    Tiwari S; Italiano JE; Barral DC; Mules EH; Novak EK; Swank RT; Seabra MC; Shivdasani RA
    Blood; 2003 Dec; 102(12):3970-9. PubMed ID: 12907454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium- and integrin-binding protein 1 regulates megakaryocyte ploidy, adhesion, and migration.
    Kostyak JC; Naik MU; Naik UP
    Blood; 2012 Jan; 119(3):838-46. PubMed ID: 22128142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The core and conserved role of MAL is homeostatic regulation of actin levels.
    Salvany L; Muller J; Guccione E; Rørth P
    Genes Dev; 2014 May; 28(10):1048-53. PubMed ID: 24831700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms.
    Espasandin YR; Glembotsky AC; Grodzielski M; Lev PR; Goette NP; Molinas FC; Marta RF; Heller PG
    J Thromb Haemost; 2015 Apr; 13(4):631-42. PubMed ID: 25604267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.